Comparison of TCM GeneXpert MTB/RIF Ultra Examination Results with AFB Microscopic Examination in Pulmonary TB Patients with MTB Detected
DOI:
https://doi.org/10.35916/thmr.v7i2.135Keywords:
TCM MTB/RIF Ultra Detected, BTA MicroscopicAbstract
Tuberculosis (TB) is a disease in Indonesia with the second largest number of cases in the world after India. One of the TB-free strategies is early diagnosis with bacteriological laboratory examination for rapid treatment, thereby reducing the incidence rate. WHO recommends the GeneXpert molecular rapid test for confirming the diagnosis of TB. The TB diagnosis is confirmed by Acid-Fast Bacilli (AFB) microscopic examination for laboratories with difficulty accessing rapid molecular tests. The study aims to compare the rapid molecular test GeneXpert MTB/RIF Ultra examination with Ziehl-Neelsen stained AFB microscopic examination in diagnosing lung patients who have been detected with Mycobacterium tuberculosis very low, low, medium, and High (MTB detected)—the type of observational analytical study, with a cross-sectional design to understand the differences. The sampling technique is a total sampling of 30 samples, and data analysis using the Wilcoxon statistical test. Of the 30 samples tested for Mycobacterium tuberculosis (MTB), the Molecular Rapid Test identified all samples as positive (100%). In contrast, AFB microscopy detected only 23 positive cases (76.67%) and failed to detect MTB in 7 samples (23.33%). Based on bacterial load classification, three samples (10%) were categorized as very low, with AFB results showing two negatives (6.67%) and one scanty (3.33%). Among the nine low-load samples (30%), five were AFB-negative (16.67%) and four were positive (1+) (13.33%). In the seven medium-load samples (23.33%), microscopy detected five samples as 1+ (16.67%), two as 2+ (6.67%), and one as 3+ (3.33%). Of the 11 high-load samples (36.67%), AFB identified three as 2+ (10%) and eight as 3+ (23.33%). The conclusion of the results of the Molecular Rapid Test examination with AFB microscopic there shows a significant difference (P < 0.025) < ? (0.05). It is recommended that further research be conducted to compare three bacteriological examinations, namely rapid molecular test, AFB microscopic, and culture, as a gold standard examination.
References
Nakate P, Patil S, Patil S, Purohit H, Shelke Y, Kinare S. Comparison of diagnostic efficacy of GeneXpert MTB/RIF assay with Ziehl Neelsen staining & microscopy in diagnosis of pulmonary tuberculosis. Int J Med Microbiol Trop Dis. 2019;5:218-211.
World Health Organization. Global Tuberculosis Report 2022 [Internet]. Geneva: WHO; 2022. accessed in July 2025. https://iris.who.int/bitstream/handle/ 10665/363752/9789240061729-eng.pdf
Pai M, Swaminathan S. India is well placed to scale innovations in tuberculosis diagnostics. Indian J Med Res. 2023;157:114-7. doi: 10.4103/ijmr.ijmr_243_23.
Sharma N, Basu S, Chopra KK. Achieving TB elimination in India: The role of latent TB management. Indian J Tuberc. 2019;66:30-3. doi: 10.1016/j.ijtb.2018.10.006.
Pandey P, Pant ND, Rijal KR, Shrestha B, Kattel S, Banjara MR, Maharjan B, Kc R. Diagnostic Accuracy of GeneXpert MTB/RIF Assay in Comparison to Conventional Drug Susceptibility Testing Method for the Diagnosis of Multidrug-Resistant Tuberculosis. PLoS One. 2017 Jan 12;12(1):e0169798
Evans CA. GeneXpert—a game-changer for tuberculosis control? PLoS Med. 2011;8:e1001064. doi: 10.1371/journal.pmed.1001064.
Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep. 2009;58:7-10.
Singh P, Ranjan PK, Kumar R, Singh S. A comparative study of the diagnostic efficacy of CB-NAAT and ZN staining. Int J Heal Clin Res. 2020;3:153-9.
Shah I, Gupta Y. Role of molecular tests for diagnosis of tuberculosis in children. Pediatr Oncall J. 2015;12:1-3.
Central TB Division. Technical and Operational Guidelines for Tuberculosis Control in India. 2016. accessed in July 2025. https://tbcindia-wp.azurewebsites.net/wp-content/uploads/2023/05/TOG.zip
Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran: Tatalaksana Tuberkulosis. Jakarta: Kementerian Kesehatan RI; 2020.
Murtafi'ah NM, Fadhilah FR, Krisdaryani R. Perbandingan Hasil Pemeriksaan Mycobacterium Tuberculosis Dengan Genexpert Dan Pewarnaan Ziehl Neelsen Di Rumah Sakit Mitra Anugrah Lestari. Riset Informasi Kesehatan. 2020;9(2):188.
Relasiskawati. Uji Kesesuaian Hasil Pemeriksaan Mikroskopis Basil Tahan Asam Metode Ziehl Neelshen dengan Tes Cepat Molekuler (GeneXpert) Pada Pemeriksaan Tuberculosis Paru Dari Sampel Sputum. Universitas Perintis Indonesia; 2020.
Nuryaningsih E, Mulyanto A, Kurniawan K, Mujahid I. Proporsi Hasil Pemeriksaan Pewarnaan Zhiel Neelsen Dengan Tes Cepat Molekuler Pada Tuberkulosis Paru. J Med Lab Sci. 2023;3(2):83-8.
Susanti D. Pemeriksaan Basil Tahan Asam (BTA) pada Sputum Penderita Batuk ?2 Minggu Di Poliklinik Penyakit Dalam BLU RSUP. Prof. Dr. RD Kandou Manado. J e-CliniC. 2013;1(1).
Nisa W. Perbandingan Tes Cepat Molekuler Xpert MTB/RIF dengan Uji Mikroskopis BTA dalam Mendiagnosis Tuberkulosis Paru di Puskesmas Landasan Ulin Timur. Politeknik Kesehatan Banjarmasin; 2022.
Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia Nomor 67 Tahun 2016 Tentang Penanggulangan Tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia; 2016.
Rafika R, Chaerunnisa C, Nurdin N. Deteksi Mycobacterium Tuberculosis Dengan Variasi Volume Sputum Penderita TB Menggunakan Metode Tes Cepat Molekuler. J Medika. 2022;7(1):16-21.
Listyowati R, Qurrohman MT. Pengaruh Kualitas Sputum Terhadap Hasil Pemeriksaan Test Cepat Molekuler Dan Kultur Media Cair Pada Pasien Rawat Inap Di RS Paru dr Ario Wirawan Salatiga. J Nurs Health. 2024;9(4):471-6.
Kementerian Kesehatan Republik Indonesia. Petunjuk Teknis Pemeriksaan Tuberkulosis menggunakan Tes Cepat Molekuler Genexpert. Jakarta: Kementerian Kesehatan RI; 2023a.
Kementerian Kesehatan Republik Indonesia. Petunjuk Teknis Pemeriksaan Mikroskopis Tuberkulosis. Jakarta: Kementerian Kesehatan RI; 2023b.
Aminah S, Handoko A, Marhamah M. Hubungan Kualitas Spesimen Dahak Dengan Gradasi Hasil Pemeriksaan BTA Pada Penderita TB Paru Di Kabupaten Pringsewu Tahun 2012. J Analis Kesehatan. 2017;2(2):290-6.
Da Silva HR, Maulani Y. Perbandingan Hasil Pemeriksaan Mikroskopis Sputum BTA Terhadap Metode PCR (Genexpert) Pada Pasien Tuberculosis Paru. Plenary Health. 2024;1(3):455-60.
World Health Organization. Global Tuberculosis Report 2017 [Internet]. Geneva: WHO; 2017. accessed in July 2025. https://iris.who.int/bitstream/handle/ 10665/259366/9789241565516-eng.pdf
Chaudhary DA, Kaur DI, Harshvardhan D, Gupta DV. Comparing diagnostic accuracy of CB-NAAT and ZN staining in diagnosis of pulmonary and extra-pulmonary tuberculosis cases at tertiary care teaching hospital of north India. Innov J Med Health Sci. 2019;9:635-45.
Chinedum OK, Emwiomwan A, Ifeanyi OE, Babayi A. Comparative analysis of Ziehl-Neelsen and GeneXpert techniques for the diagnosis of tuberculosis in human immuno-deficiency virus positive patients in Benin City. Ann Clin Lab Res. 2017;5:208.
Bajrami R, Mulliqi G, Kurti A, Lila G, Raka L. Comparison of GeneXpert MTB/RIF and conventional methods for the diagnosis of tuberculosis in Kosovo. J Infect Dev Ctries. 2016;10:418-22. doi: 10.3855/jidc.7569.
Dzodanu EG, Afrifa J, Acheampong DO, Dadzie I. Diagnostic yield of fluorescence and Ziehl-Neelsen staining techniques in the diagnosis of pulmonary tuberculosis: a comparative study in a district health facility. Tuberc Res Treat. 2019;2019:4091937. doi: 10.1155/2019/4091937.
Chen P, Shi M, Feng GD, Liu JY, Wang BJ, Shi XD, Ma L, Liu XD, Yang YN, Dai W, Liu TT, He Y, Li JG, Hao XK, Zhao G. A highly efficient Ziehl-Neelsen stain: identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid. J Clin Microbiol. 2012 Apr;50(4):1166-70
Zaporojan N, Negrean RA, Hodi?an R, Zaporojan C, Csep A, Zaha DC. Evolution of laboratory diagnosis of tuberculosis. Clin Pract. 2024;14:388-416. doi: 10.3390/clinpract14020030.
Banerjee S, Severn M. CADTH Rapid Response Report: Summary With Critical Appraisal. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020.
Yadav S, Rawal G, Jeyaraman M, Jeyaraman N. Advancements in tuberculosis Diagnostics: a comprehensive review of the critical role and future prospects of Xpert MTB/RIF Ultra technology. Cureus. 2024;16:e57311. doi: 10.7759/cureus.57311.
Osei Sekyere J, Maphalala N, Malinga LA, Mbelle NM, Maningi NE. A comparative evaluation of the new GeneXpert MTB/RIF Ultra and other rapid diagnostic assays for detecting tuberculosis in pulmonary and extra pulmonary specimens. Sci Rep. 2019;9:16587. doi: 10.1038/s41598-019-53086-5.
